谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Supplementary Table S2. from Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor–Positive Advanced Breast Cancer

Maura N. Dickler,Cristina Saura,Donald A. Richards,Ian E. Krop,Andrés Cervantes,Philippe L. Bedard,Manish R. Patel,Lajos Pusztai,Mafalda Oliveira,Alison K. Cardenas,Na Cui,Timothy R. Wilson,Thomas J. Stout,Michael C. Wei,Jerry Y. Hsu,José Baselga

crossref（2023）

引用 0|浏览15
暂无评分
摘要

Serious adverse events (SAEs) regardless of attribution in the safety population

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要